Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$13.37
+0.90%
Mkt Cap $485.47M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (7 analysts)
$36.00
Range $36.00 – $36.00
Implied Upside
+169.3%
Consensus $36.00 vs current $13.37
NASDAQ·Healthcare·Biotechnology
$13.37
+0.90%
Mkt Cap $485.47M
Buy
4
Hold
1
Sell
0
Price Target (7 analysts)
$36.00
Range $36.00 – $36.00
+169.3%
Consensus $36.00 vs current $13.37